Emcure and Gennova to resume mRNA collaboration with HDT
HDT has granted a license to Gennova to use HDT’s patented mRNA vaccine technology in multiple fields.
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
HDT Biotech
Gennova’s mRNA vaccine candidate for COVID-19 gets DCGI nod for human clinical trials
It is an indigenous mRNA vaccine candidate supported with seed grant under the Ind-CEPI mission of Department of Biotechnology of…